Sun et al. (41) demonstrated that the mineralocorticoid receptor on T cells regulates IFNγ production and that targeted deletion of this receptor significantly reduces blood pressure in angiotensin II-induced hypertension. The gene discussed is NR3C2; the disease is hypertensive disorder.